vs
Side-by-side financial comparison of PERDOCEO EDUCATION Corp (PRDO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $211.6M, roughly 1.4× PERDOCEO EDUCATION Corp). On growth, PERDOCEO EDUCATION Corp posted the faster year-over-year revenue change (20.0% vs -6.4%). Over the past eight quarters, PERDOCEO EDUCATION Corp's revenue compounded faster (12.2% CAGR vs 4.2%).
Perdoceo Education Corporation (PRDO) is a public company that owns five for-profit universities in the United States: American Intercontinental University, Colorado Technical University, California Southern University, Trident University International, and University of St. Augustine for Health Sciences. The company was previously known as Career Education Corporation.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PRDO vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $211.6M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 19.8% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | 20.0% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $0.55 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $211.6M | $295.9M | ||
| Q3 25 | $211.9M | — | ||
| Q2 25 | $209.6M | $317.0M | ||
| Q1 25 | $213.0M | $316.2M | ||
| Q4 24 | $176.4M | $297.0M | ||
| Q3 24 | $169.8M | $289.5M | ||
| Q2 24 | $166.7M | $306.1M | ||
| Q1 24 | $168.3M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $39.9M | — | ||
| Q2 25 | $41.0M | $-17.7M | ||
| Q1 25 | $43.7M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $38.3M | $33.6M | ||
| Q2 24 | $38.4M | $40.6M | ||
| Q1 24 | $39.4M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 19.8% | 18.4% | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 24.5% | -7.5% | ||
| Q1 25 | 24.3% | 12.2% | ||
| Q4 24 | 21.1% | 16.0% | ||
| Q3 24 | 26.4% | 13.8% | ||
| Q2 24 | 27.6% | 15.0% | ||
| Q1 24 | 27.5% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 18.8% | — | ||
| Q2 25 | 19.6% | -5.6% | ||
| Q1 25 | 20.5% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 22.5% | 11.6% | ||
| Q2 24 | 23.0% | 13.3% | ||
| Q1 24 | 23.4% | 16.2% |
| Q4 25 | $0.55 | $0.24 | ||
| Q3 25 | $0.60 | — | ||
| Q2 25 | $0.62 | $-0.11 | ||
| Q1 25 | $0.65 | $0.14 | ||
| Q4 24 | $0.46 | $0.22 | ||
| Q3 24 | $0.57 | $0.21 | ||
| Q2 24 | $0.57 | $0.26 | ||
| Q1 24 | $0.59 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $111.0M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $972.4M | $2.0B |
| Total Assets | $1.2B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.0M | $172.9M | ||
| Q3 25 | $159.5M | — | ||
| Q2 25 | $172.1M | $162.2M | ||
| Q1 25 | $132.1M | $140.7M | ||
| Q4 24 | $109.1M | $177.5M | ||
| Q3 24 | $238.0M | $187.5M | ||
| Q2 24 | $127.9M | $152.9M | ||
| Q1 24 | $125.8M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $972.4M | $2.0B | ||
| Q3 25 | $997.9M | — | ||
| Q2 25 | $984.6M | $1.9B | ||
| Q1 25 | $970.3M | $2.0B | ||
| Q4 24 | $959.5M | $2.1B | ||
| Q3 24 | $935.4M | $2.1B | ||
| Q2 24 | $899.5M | $2.1B | ||
| Q1 24 | $866.1M | $2.0B |
| Q4 25 | $1.2B | $2.5B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.2B | $2.7B | ||
| Q3 24 | $1.1B | $2.7B | ||
| Q2 24 | $1.1B | $2.7B | ||
| Q1 24 | $1.1B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | — |
| Free Cash FlowOCF − Capex | $37.9M | — |
| FCF MarginFCF / Revenue | 17.9% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $216.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.1M | — | ||
| Q3 25 | $41.2M | — | ||
| Q2 25 | $78.8M | $98.2M | ||
| Q1 25 | $65.1M | $41.1M | ||
| Q4 24 | $17.6M | $84.3M | ||
| Q3 24 | $51.0M | $63.9M | ||
| Q2 24 | $38.5M | $75.5M | ||
| Q1 24 | $54.5M | $81.0M |
| Q4 25 | $37.9M | — | ||
| Q3 25 | $39.4M | — | ||
| Q2 25 | $76.0M | $93.3M | ||
| Q1 25 | $63.4M | $31.0M | ||
| Q4 24 | $16.0M | $77.5M | ||
| Q3 24 | $50.0M | $54.7M | ||
| Q2 24 | $37.7M | $57.5M | ||
| Q1 24 | $53.3M | $64.5M |
| Q4 25 | 17.9% | — | ||
| Q3 25 | 18.6% | — | ||
| Q2 25 | 36.3% | 29.4% | ||
| Q1 25 | 29.8% | 9.8% | ||
| Q4 24 | 9.1% | 26.1% | ||
| Q3 24 | 29.4% | 18.9% | ||
| Q2 24 | 22.6% | 18.8% | ||
| Q1 24 | 31.7% | 21.3% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.3% | 1.5% | ||
| Q1 25 | 0.8% | 3.2% | ||
| Q4 24 | 0.9% | 2.3% | ||
| Q3 24 | 0.6% | 3.2% | ||
| Q2 24 | 0.5% | 5.9% | ||
| Q1 24 | 0.7% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 1.49× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 1.33× | 1.90× | ||
| Q2 24 | 1.00× | 1.86× | ||
| Q1 24 | 1.38× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRDO
| CTU | $107.0M | 51% |
| AIUS | $60.8M | 29% |
| University Of St Augustine For Health Sciences Llc | $43.7M | 21% |
| Other | $1.1M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
